 |
|
Danazol for Lupus Thrombocytopenia
Catherine Marino, MD;
Perry Cook, MD
Arch Intern Med. 1985;145(12):2251-2252.
Abstract
• Danazol therapy was used in the treatment of three consecutive patients with lupus-associated thrombocytopenia refractory to high-dose prednisone therapy (two patients) or in whom high-dose prednisone therapy was considered contraindicated (one patient). Treatment was associated in each case with an increase in platelet count but was complicated in two of three patients by the development of a diffuse maculopapular rash that promptly resolved following discontinuation of danazol therapy. Retreatment of one patient with danazol was associated with immediate recurrence of the rash. We suggest that danazol therapy deserves further evaluation in the treatment of lupus-associated thrombocytopenia, but advise that patients be carefully monitored for rash.
(Arch Intern Med 1985;145:2251-2252)
Author Affiliations
From the Department of Medicine, Divisions of Rheumatology and Hematology, Queens Hospital Center, Affiliation of Long Island Jewish Hospital Center, Jamaica, NY.
Footnotes
Accepted for publication Aug 8, 1985.
Reprint requests to Queens Hospital Center, B-305, 82-68 164th St, Jamaica, NY 11432 (Dr Marino).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The management of peripheral blood cytopenias in systemic lupus erythematosus
Hepburn et al.
Rheumatology (Oxford) 2010;49:2243-2254.
ABSTRACT
| FULL TEXT
Efficacy of Danazol with Autoimmune Thrombocytopenia
Kim et al.
CLIN APPL THROMB HEMOST 1997;3:251-255.
ABSTRACT
Danazol for the Treatment of Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus
WEST and JOHNSON
ANN INTERN MED 1988;108:703-706.
ABSTRACT
|
